Showing results (211-220 of 1,947) with videos related to

Sort By:
Pageof 195
Expert Review of Neurotherapeutics|February 22, 2019
Modification of CSF findings in multiple sclerosis in the era of rapidly expanding treatment optionsIoanna Giotaki, Peter Lange, Martin S Weber
JAMA Neurology|February 13, 2023
Targeting B Cells and Microglia in Multiple Sclerosis With Bruton Tyrosine Kinase Inhibitors: A ReviewSarah Dybowski, Sebastian Torke, Martin S Weber
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2015
Do dogs sense hypoglycaemia?K S Weber, M Roden, K Müssig
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|February 6, 2019
[Indications and limitations of ECMO therapy : Considerations on evidence, treatment decisions and ethical challenges]C Karagiannidis, T Bein, S Weber-Carstens
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 7, 2015
Quality of life in maltreated children and adult survivors of child maltreatment: a systematic reviewS Weber, A Jud, M A Landolt
Experimental & Molecular Medicine|February 13, 2026
Microglia-associated progression of multiple sclerosis: target identification and therapeutic engagement in human in vitro modelsAlica Blenkle, Anastasia Geladaris, Martin S Weber
European Journal of Immunology|May 1, 1997
CD43 (leukosialin, sialophorin) expression is differentially regulated by retinoic acidsM Babina, S Weber, B M Henz
Current Neurology and Neuroscience Reports|March 6, 2016
The Use of Oral Disease-Modifying Therapies in Multiple SclerosisBenedikt Kretzschmar, Hannah Pellkofer, Martin S Weber
Pageof 195